Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT07234058
Brief Title:
Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
Official Title:
A NON-COMPARATIVE PHASE IIR TRIAL ASSESSING FIANLIMAB PLUS CEMIPLIMAB PLUS PEMETREXED-PLATINUM CHEMOTHERAPY OR CEMIPLIMAB PLUS PEMETREXED-PLATINUM CHEMOTHERAPY FOR TREATMENT-NAIVE PLEURAL MESOTHELIOMA (PM) PATIENTS
Acronym:
LAG-MAPS
Study:
NCT07234058
Protocol Section:
NCT07234058